Lapsed Feb 21, 2025 on the fee record · High confidence
20-year base term ends Feb 12, 2029
Second maintenance fee unpaid; grace period ended.
Held by Intarcia Therapeutics Inc.
Filed Dec 23, 2014 as application 14/580,320 · Granted Feb 21, 2017
Base term, 20 years from filing, plus 43 days of patent term adjustment (USPTO delay)
Today
Lapsed Feb 21, 2025
2009
2029
Clock starts
Feb 12, 2009
Feb 12, 2009
No longer in force
Feb 21, 2025
Feb 21, 2025
Granted
Feb 21, 2017
Feb 21, 2017
Term would have run to
Mar 27, 2029
Mar 27, 2029
base term
patent term adjustment
after the term ends
fee events
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
43
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Mar 27, 2029: its 20-year base term plus 43 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 12, 2009, when application 12/378,341, the earliest non-provisional in its chain, was filed (this one was filed Dec 23, 2014) | Feb 12, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +43 days, USPTO patent term adjustment record | Mar 27, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed Feb 21, 2025 | High confidence |
| Computed term end | The steps above, in order | Feb 21, 2025 | High confidence |
This family
| US 8,343,140 | Lapsed on the fee record Jan 2025 | Jan 2025 |
| US 8,926,595 | In force Sep 2029 | Sep 2029 |
| US 9,572,889 | this patent Feb 2025 | Feb 2025 |
| Application 15/362,240 | Abandoned not computed | not computed |
| US 10,441,528 | In force Feb 2029 | Feb 2029 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 3, 2015 Reel 35078, frame 117 | Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Young, Bing | Intarcia Therapeutics Inc. | Assignment of Assignor's Interest |
| Mar 11, 2015 Reel 35181, frame 916 | Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, Bing | Intarcia Therapeutics Inc. | Corrective Assignment to Correct the Sixth Assignor's Last Name Previously Recorded at Reel: 035078 Frame: 0117. Assignor(S) Hereby Confirms the Assignment. |
| Oct 9, 2019 Reel 50673, frame 20 | Intarcia Therapeutics, Inc.; Intarcia Ireland Limited | Midcap Financial Trust, As Agent | Security Interest |
| Oct 23, 2019 Reel 50801, frame 267 | Intarcia Therapeutics, Inc. | Baupost Private Investments Bviv-3, L.L.C., as Collateral Agent | Security Interest |
| Jan 29, 2020 Reel 51739, frame 453 | Baupost Private Investments Bviv-3, L.L.C. as Collateral Agent | Intarcia Therapeutics, Inc. | Release of Security Interest |
| Apr 17, 2020 Reel 52433, frame 1 | Midcap Financial Trust, As Agent | Intarcia Therapeutics, Inc.; Intarcia Ireland Limited | Release of Security Interest |
| Apr 17, 2020 reel/frame not recorded | Midcap Financial Trust, As Agent | Intarcia Therapeutics, Inc. | Release of Security Interest |
| Apr 17, 2020 reel/frame not recorded | Midcap Financial Trust, As Agent | Intarcia Ireland Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 43 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
41
later US patents cite this one
That is top 10% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.